Guideline Panel Meeting: Neurologic Lower Urinary Tract Dysfunction (2019)

Linthicum, MD US
November 9, 2019 to November 10, 2019

The Neurologic Lower Urinary Tract Dysfunction Guideline Panel will be meeting to develop the statements and guideline to be released at the Annual Meeting in 2020.

Target Audience

  • Urologists

Learning Objectives

After attending this activity, participants will be able to:

  • Expand and update urology knowledge base
  • Analyze clinical skills and patient care methods towards improving their quality
  • Identify methods to improve teaching skills from familiarity with the most recent information and its clinical application
  • Demonstrate written communication skills from exposure to peer review of written materials
Course summary
Available credit: 
  • 11.00 AMA PRA Category 1 Credit™
  • 11.00 Non-Physician Participation
Course opens: 
11/09/2019
Course expires: 
11/10/2022
Event starts: 
11/09/2019 - 8:00am
Event ends: 
11/10/2019 - 11:45pm
Rating: 
0

Day 1-November 9, 2019

7:30am                Breakfast

8:00am                Welcome & Introductions                                                                       Abid Khan

8:10am                Conflict of Interest Disclosures and Panel Responsibilities         Nenellia Bronson

                               CME

8:30am                Guidelines Stages Overview                                                                   Nenellia Bronson

8:45am                Categorizing Guidelines Statements                                                    Nenellia Bronson

9:15am                Evidence Report Overview                                                                      Dr. Martha Faraday                       

10:00am             Evidence Report Discussion/Statement Development                    Panel

10:30am             Break (10 min)                                                               

12:30pm             Lunch

1:00pm                Guideline Statement Development                                                        Panel

2:45pm                Break (10 min)

4:30pm                Recap and Day 2 Agenda                                                                           Panel

4:45pm                Shuttle Departs AUA to hotel                                                     

6:00pm                Shuttle departs from hotel to dinner

 

 

Day 2-November 10, 2019

8:00am                Breakfast

8:30am                Drafting Guideline Statements CONT’D                                                Panel

10:30am             Break (10 min)

11:45am             Discussion of Treatment Algorithm                                                       Panel

12:15pm             Next Steps                                                                                                      Nenellia Bronson

12:30pm             Meeting Adjourned

AUA Headquarters
1000 Corporate Blvd
Linthicum, MD 21090
United States
NameCompanyRoleFinancial
David Ginsberg, MD
Panel Chair
Neurourology and UrodynamicsHealth PublishingNo
Society of Urodynamics, Female Pelvic Medicine & Urogenital ReconstructionLeadership PositionNo
Victor Nitti, MD
Chair of Education
MedtronicScientific Study or TrialNo
Michael Abern, MD
Chair of COI Review Work Group
Dept. of Defense Prostate Cancer Research ProgramScientific study or Trial, Consultant or AdvisorYes
American Urological Association Office of EducationConsultant or AdvisorYes
Martha Faraday, PhD
Methodologist
Nothing to disclose  
Nenellia Bronson
Staff
Nothing to disclose  

 

Accreditation: The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation: The American Urological Association designates this Committee learning activity for a maximum of 11 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Evidence Based Content: It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

AUA Disclosure Policy: All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) participating in an educational activity provided by the AUA are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual's relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

Resolution of Identified Conflict of Interest: All disclosures will be reviewed by the program/course directors or editors for identification of conflicts of interest. Peer reviewers, working with the program directors and/or editors, will document the mechanism(s) for management and resolution of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to resolve conflict of interest:

  • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or Education Conflict of Interest Review Committee or its subgroup
  • Limit content to evidence with no recommendations
  • Introduction of a debate format with an unbiased moderator (point-counterpoint)
  • Inclusion of moderated panel discussion
  • Publication of a parallel or rebuttal article for an article that is felt to be biased
  • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
  • Divestiture of the relationship by faculty

Off-label or Unapproved Use of Drugs or Devices: It is the policy of the AUA to require the disclosure of all references to off-label or unapproved uses of drugs or devices prior to the presentation of educational content. The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

Special Assistance/Dietary Needs: The American Urological Association complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

Available Credit

  • 11.00 AMA PRA Category 1 Credit™
  • 11.00 Non-Physician Participation

Accreditation Period

Course opens: 
11/09/2019
Course expires: 
11/10/2022
Please login or register to take this course.

This activity is restricted to members of the Neurologic Lower Urinary Tract Dysfunction Guideline Panel.